IntroductIon
Most breast cancer (BC) survivors are overweight or obese and approximately 60-80% gain weight during chemotherapy. 1, 2 Within two years of BC diagnosis, weight gain between 2 kg and 6 kg 3, 4 has been reported. Black women are more likely to be overweight or obese before BC is diagnosed compared with Whites, 5 and they gain more weight following diagnosis and during treatment. 6 In contrast to women of normal weight, those with a high body mass index have twice the risk of BC recurrence and death. [7] [8] [9] Consequently, for Black women, who have an increased recurrence risk compared with Whites, 10 obesity is of additional concern.
Obesity is also associated with increased inflammation and may influence the risk of initial BC cancer development as well as its progression. 11, 12 Fat tissue functions as a secretory organ for adipokines, protein signals, and other factors, including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Inflammation is known to increase cancer cell proliferation and angiogenesis, 13 and IL-6 in particular has been associated with cancer progression and shorter survival in BC.
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In the setting of insulin resistance, various tissues show low cell sensitivity to insulin activity, resulting in a chronic compensatory hyperinsulinemia. By continuously stimulating insulin signalling in sensitive tissues, high levels of circulating insulin cause increased cell division and reduced cell death (antiapoptosis). 17 
Methods
Following University of Maryland Institutional Review Board study approval, recruitment of BC participants was done through oncology practices, community churches and health fairs. Women in the control groups were recruited from the Baltimore/Washington area by advertisements to participate in weight loss and exercise studies. 20 Women in the BC group self-identified as African American or Black, had been previously diagnosed with BC stage I-III, were aged 40-75 years, had no history of diabetes, were post-menopausal, had a body mass index (BMI) ≥25 kg/m 2 , had completed adjuvant treatment at least six months prior (with the exception of hormonal therapy), had received medical clearance for study participation from a health care provider, and were English speaking. In the group without BC, women also self-identified as African American or Black, were post-menopausal, had no history of diabetes, and had a BMI ≥25 kg/m 2 . Women in the non-BC group were divided into older (aged >57 years) and younger (aged ≤57 years). The younger non-BC group was the primary group for comparison because of similar age. The older non-BC group was also compared with the BC group in order to investigate how a normal aging population compared with the BC group on the measures of interest.
Following informed consent, height (cm) and weight (kg) were measured to calculate BMI. Waisthip ratio (WHR) was calculated by measuring waist circumference at the narrowest point superior to the hip. This value was divided by the circumference of the hip, measured at its greatest gluteal protuberance. After a 12-hour fast, participants came to the Baltimore Veterans Affairs Medical Center Geriatric Research, Education, and Clinical Center for a blood draw. Blood samples were collected for plasma (heparin) and placed in test tubes. Samples were placed in prechilled test tubes containing 1.5 mg EDTA/mL of blood and centrifuged at 2,000 × g for 10 minutes at 4°C.
Biomarker Assays
Plasma glucose concentrations were measured in duplicate using the glucose oxidase method (2300 STAT Plus, YSI, Yellow Springs, OH). Plasma insulin was meain insulin sensitivity have been documented, 19 which further compounds insulin resistance progression. Although exact mechanisms remain unknown, hyperinsulinemia and the commensurate increase of insulin-like growth factor may play a role in breast cancer recurrence in insulin-resistant patients.
Little is known about differences in inflammation and insulin resistance in Black women with and without BC. The purpose of our analysis, therefore, was to compare 21 Plasma triglyceride and cholesterol were analyzed by enzymatic methods (Hitachi model 917 analyzer), and high-density lipoprotein cholesterol was measured in the supernatant after precipitation with dextran sulfate. Low-density lipoprotein was calculated using the Friedewald equation: LDL-C = total cholesterol -(TG/5 + Hdl-C). 22 All determinations were performed in duplicate (CRP) or triplicate (TNFa, IL-6, IL-8). All assays contained quality control high and low level internal standard pools. Cytokines (TNFa, IL-6, IL-8, CRP) were measured by electrochemiluminescence using a Sector Imager 6000 (Meso Scale Discoveries, Rockville, MD). The inter-assay and intraassay coefficients of variation (CV) were 10%-15%. Adiponectin was measured by radioimmune assay (Millapore, Inc. St. Charles, MO).
To address skewness of some variables, transformations were done for the following variables:
insulin, IL-6, IL-8, and HOMA-IR. Variables reported reflect pre-transformation values. Comparisons of mean values for each measurement were done between the BC group and non-BC comparison groups (older and younger) using independent t-tests. Stata13 was used for statistical analysis (StataCorp, College Station, TX).
results
The population of women with a history of BC (n=19) had an age range of 40- 
Comparisons between Women with BC and Older Controls
Compared with women without BC in the older control group, fasting glucose levels for those with BC were 1.58 times higher (P=.024); insulin was 1.63 times higher and HOMA-IR 1.38 times higher in the BC group (P<.001 for both). Inflammatory markers of IL-1b and TNFα were elevated 
dIscussIon
We identified significant insulin resistance in this obese, non-diabetic population of Black BC survivors; this factor may contribute to increased risk of BC recurrence in addition to the well-documented risk of type 2 diabetes. Obese patients often develop insulin resistance, with various tissues showing low cell sensitivity to insulin activity, resulting in a chronic compensatory hyperinsulinemia. By continuously stimulating insulin signalling in sensitive tissues, high levels of circulating insulin cause increased cell division and reduced cell death. 18, 23 Although exact mechanisms remain unknown, hyperinsulinemia and the commensurate increase of insulin-like growth factors, may play a role in BC recurrence in insulin-resistant patients. Elevated glucose levels and insulin resistance have been strongly associated with BC recurrence. 15, 16 Our comparisons of the BC group and both control groups (same age and approximately a decade older) revealed that BC patients had markedly higher insulin resistance in both cases, suggesting that BC itself or perhaps aspects of treatment confer additional risk of insulin resistance beyond the normal aging changes. In our population of Black women with a history of BC, HOMA-IR values were much greater than previously reported in the literature. In a sample of 130 Black women with BC and aged 52 (SD±7.4) years, mean HOMA-IR was reported at 4.8, one-third lower than our population of patients of the same age. 24 Similar findings have been reported in a population of 144 Kuwati BC patients, where HOMA-IR values were 28% greater in patients compared with controls (3.6±4 vs 2.6±.5; P<.001). 25 Our BC population had 1.6 times higher HOMA-IR values compared with age similar controls. It is possible that length of time from treatment, BC stage, and comorbidities may have played a role in observed insu- 
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lin resistance in Black BC patients. Obesity is the most common cause of insulin resistance and may be considered a chronic inflammatory condition. Obesity leads to altered expression of adipokines and cytokines, including TNF-α, IL-6, IL1β. 26 Cancer-associated inflammation also occurs in conjunction with specific cell types, including pro-inflammatory cytokines. 13 As part of this low-grade inflammatory state associated with obesity, overproduction of cytokines may influence the risk of initial BC cancer development as well as its progression. 27 Inflammation is known to increase cancer cell proliferation and angiogenesis. 13 In our study population of Black women, in which each of the three groups did not differ on BMI, TNF-α was significantly higher in the BC group compared with both the age similar and older control groups. The primary role of TNF-α is in regulation of immune cells, and when overproduced, results in a chronic inflammatory state that leads to insulin resistance. 28 Since TNF-α was more than doubled in the BC group compared with the non BC groups, some aspect of the cancer process, in addition to obesity, may drive the elevation. This finding requires further evaluation in future studies.
In the BC group, IL-6 levels were higher compared with the agesimilar control group, and IL-8 levels were lower compared with the older control group. IL-6 and IL-8 are additional cytokines associated with both obesity and BC, although their exact role in BC development remains unclear.
12,29 IL-6 expression is positively correlated with obesity and insulin resistance, and IL-6 activation of protein signaling has been shown to stimulate cancer cell proliferation and suppress antitumor activity. 30 Recent survival. 14 IL-8 has also been positively associated with estradiol in BC where estradiol increased IL-8. Consequently, the secretion of IL-8 was inhibited post anti-estrogen tamoxifen both in vitro and in vivo in tumors of nude mice, which may offer an explanation for our findings of lower IL-8 in the BC group compared with the older control group. 34 Upregulation of IL1-β has been documented in the adipose tissue of obese and insulin-resistant mouse models. 35 IL-1-β may also mediate the function of pancreatic beta cells during diabetes development, [36] [37] [38] suggesting the role that IL-1-β plays in obesity and insulin resistance. In gliomas, IL1-β is postulated to be responsible for stem cell proliferation, sphere formation, and tumorigenicity, 39 and it is possible that it may have activity in other tumor types.
Adipokines are major contributing factors to both obesity and cancer. 40 Adiponectin is a hormonal growth factor, and epidemiological studies have found an inverse association between adiponectin levels and BC risk. [41] [42] [43] Although adiponectin levels were not significantly different between age similar groups in our study (P=.08), the reduced number of evaluable participants in the control groups may have affected this analysis. The trend toward lower adiponectin levels in the BC group compared with the age-similar controls suggests a potential association between BC and adiponectin, and we recommend continued surveillance of this important adipokine.
A limitation of this study includes a small sample size of participants with BC relative to each No measure of total body fat, such as a DEXA scan, was done, which could have provided supporting evidence for our findings. The higher WHR in the BC group relative to both controls, however, provides strong support for our findings of higher HOMA-IR values and inflammation in the setting of greater central obesity, which is consistent with the BC literature. 24 It is well-established that weight loss can improve insulin sensitivity and reduce inflammation in post-menopausal women without BC. [44] [45] [46] Recent work has also revealed decreased circulating levels of IL-8, IL-6 and TNF-α following a weight loss intervention for overweight and obese BC survivors. 11 Although not the focus of this study, our findings indicate that future weight loss intervention work in the BC population should evaluate changes in insulin sensitivity and pro-inflammatory cytokines in order to determine the role of fat mass reduction on markers associated with both obesity and BC risk. For Black women, for whom the recurrence risk looms especially large, these markers are critical.
